乾燥粉砕トウモロコシとトウモロコシ製品と健康: ネラティブレビュー
1School of Exercise and Nutritional Sciences San Diego State University San Diego California USA.
Food science & nutrition
|February 16, 2026
まとめ
全粒穀トウモロコシ製品は,より多くの栄養素を提供し,疫学研究によってサポートされています. 健康への影響,マキュラ健康,健康的な食品媒介としての使用を含む,全体および精製されたトウモロコシ製品に関するさらなる研究が必要である.
科学分野:
- 農業科学 農業科学とは
- 食品科学 食品科学について
- 栄養科学とは,栄養科学である.
背景:
- トウモロコシ (トウモロコシ) は主食であり,一般的にトウモロコシ粉,砂粒,粉などの製品に乾燥磨き後に消費されます.
- 干し粉砕プロセスは,全穀物または精製可能であり,全穀物製品は,と胚芽の除去中に失われるより多くの栄養素を保持します.
- アルカリ加工のステップであるニクスタマライゼーションは,特定のトウモロコシ製品にも使用されます.
研究 の 目的:
- ドライミルトトウモロコシ製品の栄養価と健康への影響を検討する.
- 精製された干し粉のトウモロコシと整体のトウモロコシの消費に関する研究のギャップを特定する.
- 有益な栄養素を運ぶために,トウモロコシベースの食品の潜在能力を探求する.
主な方法:
- 乾燥粉砕トウモロコシの消費に関する疫学研究のレビュー.
- トウモロコシ全粒粉および精製トウモロコシ製品に関する限られた臨床試験の結果の分析.
- 投与量反応研究や健康への特定の影響を含む,将来の研究分野を特定する.
主要な成果:
- 疫学研究は,干し粉のトウモロコシ全粒粉の健康上の利点を支持しています.
- 臨床試験では,全粒粉のトウモロコシについては肯定的な結果,精製トウモロコシについては混合的な結果を示しています.
- 両種類のトウモロコシ製品に関する長期的な研究のための重要な研究需要が存在します.
結論:
- 乾燥磨きトウモロコシの全粒粉は栄養価が高く,人口研究によって支持されています.
- 精製されたトウモロコシ製品と全トウモロコシ製品の長期的な健康への影響については,さらなる調査が必要である.
- 干し粉砕トウモロコシ製品は,黄斑の健康のためにゼアキサンチンを含む有益な化合物の食事摂取を増やす機会を提供します.
さらに関連する動画
07:19Quantifying Plant Soluble Protein and Digestible Carbohydrate Content, Using Corn Zea mays As an Exemplar
Published on: August 6, 2018
21.2K
08:52Method to Produce Durable Pellets at Lower Energy Consumption Using High Moisture Corn Stover and a Corn Starch Binder in a Flat Die Pellet Mill
Published on: June 15, 2016
21.7K
関連する概念動画
Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Bioavailability Study Design: Healthy Subjects Versus Patients
164
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
164
Dietary Connections
62.3K
In biological systems, most metabolic pathways are interconnected. The cellular respiration processes that convert glucose to ATP—such as glycolysis, pyruvate oxidation, and the citric acid cycle—tie into those that break down other organic compounds. As a result, various foods—from apples to cheese to guacamole—end up as ATP. In addition to carbohydrates, food also contains proteins and lipids—such as cholesterol and fats. All of these organic compounds are used...
62.3K
Bioavailability: Overview
4.6K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.6K
Bioavailability: Overview
493
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
493
